ERBI has merged with the London Biotechnology Network (LBN) and the group will operate under the ERBI name until the launch of a new identity at the ERBI Annual Conference on 2 June.
The merger, driven by requests from ERBI and LBN members, will result in member benefits including: a larger pool of companies to support business-to-business interaction; one membership providing discounted entry to conferences and events, including the ERBI Annual Conference, the Genesis Conference, the BioWednesday meetings and ERBI Network Meetings; economies of scale enabling expansion of ERBI's group-purchasing scheme, which already saves millions of pounds a year for members; and an expanded training programme focused on the needs of life-science companies.
ERBI is a not-for-profit membership company for international life science and healthcare companies, and the London Biotechnology Network (LBN) is a business network for London-based life-science organisations.
